Cary Street Partners Investment Advisory LLC Novo Nordisk A S Transaction History
Cary Street Partners Investment Advisory LLC
- $173 Billion
- Q1 2025
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 2,126 shares of NVO stock, worth $149,755. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,126
Previous 1,035
105.41%
Holding current value
$149,755
Previous $89 Million
65.82%
% of portfolio
0.09%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.33 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.04 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$873 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$868 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$836 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $159B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...